Our Summary

This research studied the use of radiofrequency myolysis (RFM), a less invasive procedure, to treat fibroids in women. The study involved 54 premenopausal women with 106 symptomatic uterine fibroids. The RFM treatment was administered in three different ways: through vaginal ultrasound, laparoscopy, and hysteroscopy.

The results showed that the size of the fibroids significantly reduced by 51.3% in the first month and up to 73.5% after 12 months. Similarly, symptoms associated with fibroids, such as heavy menstrual bleeding, painful periods, painful intercourse, and frequent urination, significantly reduced. The patients’ quality of life also improved.

The average time taken to perform the RFM procedure was 48 minutes. However, it was found that the procedure was quicker when administered through vaginal ultrasound compared to laparoscopy or hysteroscopy.

In addition, an electromagnetic virtual needle tracking system was successfully tested during the RFM procedures, and real-time contrast-enhanced ultrasound was effective in determining the length of the procedure.

In conclusion, the research suggests that radiofrequency can be a safer, less invasive procedure for treating uterine fibroids. The use of new technologies and techniques can spare healthy uterine tissue and may change future treatment methods for symptomatic uterine fibroids.

FAQs

  1. What is radiofrequency myolysis (RFM) and how is it used to treat uterine fibroids?
  2. How effective is the RFM procedure in reducing the size of fibroids and associated symptoms?
  3. What new technologies were used during the RFM procedures and how did they contribute to the procedure’s effectiveness?

Doctor’s Tip

A helpful tip a doctor might tell a patient about uterine ablation is to discuss with their healthcare provider the possibility of undergoing radiofrequency myolysis (RFM) as a less invasive treatment option for symptomatic uterine fibroids. This procedure has been shown to significantly reduce the size of fibroids and improve symptoms associated with fibroids, leading to an improved quality of life for patients. Additionally, the use of new technologies and techniques during the RFM procedure can make the treatment more efficient and effective. It is important for patients to have an open dialogue with their doctor to explore all available treatment options and determine the best course of action for their individual situation.

Suitable For

Patients who are typically recommended uterine ablation are those who suffer from symptomatic uterine fibroids, such as heavy menstrual bleeding, painful periods, painful intercourse, and frequent urination. Uterine ablation may be recommended for women who have not responded to other conservative treatments and who wish to avoid a hysterectomy. It may also be suitable for women who are not planning to have children in the future.

Timeline

Before uterine ablation:

  1. Patient experiences symptoms of uterine fibroids such as heavy menstrual bleeding, painful periods, painful intercourse, and frequent urination.
  2. Patient undergoes diagnostic tests such as ultrasound to confirm the presence of fibroids.
  3. Patient discusses treatment options with their healthcare provider and decides to undergo uterine ablation.

After uterine ablation:

  1. Patient undergoes the RFM procedure, which reduces the size of the fibroids and alleviates symptoms.
  2. Patient experiences a significant reduction in symptoms within the first month post-procedure.
  3. Patient’s quality of life improves as symptoms associated with fibroids decrease.
  4. Follow-up appointments may be scheduled to monitor the progress of the treatment and ensure the patient’s overall well-being.

What to Ask Your Doctor

  1. What are the potential risks and complications associated with uterine ablation, specifically radiofrequency myolysis?
  2. How long does the procedure typically take, and what is the recovery time?
  3. Are there any long-term effects or limitations to consider after undergoing uterine ablation?
  4. How effective is radiofrequency myolysis in reducing symptoms associated with uterine fibroids, and what is the success rate?
  5. Are there any factors that may make me a not suitable candidate for uterine ablation?
  6. Will I need any follow-up appointments or additional treatments after the procedure?
  7. How does radiofrequency myolysis compare to other uterine fibroid treatments in terms of effectiveness and recovery time?
  8. Are there any lifestyle changes or precautions I should take before or after undergoing uterine ablation?
  9. What can I expect in terms of pain management during and after the procedure?
  10. Are there any potential fertility concerns or impacts on future pregnancies to consider when choosing uterine ablation as a treatment option?

Reference

Authors: Fasciani A, Turtulici G, Siri G, Ferrero S, Sirito R. Journal: Medicina (Kaunas). 2020 Mar 12;56(3):122. doi: 10.3390/medicina56030122. PMID: 32178351